Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer(NSCLC), according to researchers from The University of Texas MD Anderson Cancer Center.
GLP-1 receptor agonists cut risk of death in inflammatory disease patients, says study – Pharmaceutical Technology
Patients with immune diseases and type 2 diabetes taking GLP-1RAs had a lower chance of death compared to those taking DPP-4is. Credit: Buravleva stock via
August 13, 2024